Streetbeat News

Stock Prices

VSEC

VSE Corporation has priced its public offering of approximately 112.7 million shares of common stock at $48.50 per share.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 12:47 pm

VIR

Vir Biotechnology's shares have dropped following the failure of its Phase 2 PENINSULA trial of VIR-2482, aimed at preventing symptomatic influenza A illness, to meet primary or secondary efficacy endpoints.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 12:46 pm

TFC

Truist Financial reported lower-than-expected Q2 earnings results, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 12:45 pm

KTTA

Pasithea Therapeutics has announced its intention to commence a $4M tender offer for 5.7M shares of its common stock at a price of $0.70 per share.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 12:45 pm

AKYA

BKNG

EW

LAZR

PFE

STLA

SWAV

TRIP

VTS

Jim Cramer, on CNBC’s 'Mad Money Lightning Round', gave his opinions on several stocks. He prefers Booking Holdings over Tripadvisor, and recommends Edwards Lifesciences over Shockwave Medical. He described Akoya Biosciences as a speculative stock and predicted a downward trend for Luminar Technologies. He supports Vitesse Energy and Stellantis, and suggested Pfizer should better utilize its funds and work more with Nurtec.

Portfolio Pulse from Lisa Levin

July 20, 2023 | 12:45 pm

AWH

Aspira Women's Health announced a registered direct offering of around 1.7 million shares at $2.75/share and $3.98/share for directors & officers, aiming to raise approximately $4.7 million. This news led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 12:44 pm

AWH

Aspira Women's Health has announced a registered direct offering of 1,694,820 shares of the company's common stock at $2.75/share and $3.98/share to the directors and officers of the company, raising $4.7M.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 12:43 pm

KTTA

LSDI

Pasithea Therapeutics Corp. (NASDAQ:KTTA) has rejected an unsolicited bid from Lucy Scientific Discovery, Inc. (NASDAQ:LSDI) to acquire all outstanding shares of Pasithea. The bid consisted of $0.60 in cash plus $0.25 worth of Lucy common stock per share. Pasithea's special committee determined that the proposal does not reflect the company's strategic value and growth prospects.

Portfolio Pulse from Happy Mohamed

July 20, 2023 | 12:41 pm

SGBX

Safe & Green Holdings Corp. (NASDAQ:SGBX) has provided an update on the planned spinoff of Safe & Green Development Corp (SG DevCo) to become a standalone company listed on Nasdaq. The company plans to distribute 30% of SG DevCo to its current shareholders, with Safe & Green Holdings retaining 70%. The fair market value of SG DevCo is valued at $74 million. The company is awaiting final review and approval of the transaction by Nasdaq.

Portfolio Pulse from Happy Mohamed

July 20, 2023 | 12:39 pm

BMI

Badger Meter (NYSE:BMI) expects to face tougher comparisons in the second half of the year due to macroeconomic uncertainty. However, the company is well-positioned to sustain its pattern of profitable growth due to its innovative offerings and end market resiliency. It also expects benefits from stabilizing supply chain and inflation dynamics for the rest of the year.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 12:38 pm